Lixte Biotechnology Holdings, INC. (LIXT) SEC Filings — 2024

Filings

• Lixte Biotechnology Changes HQ, Reports Officer/Director Updates — 8-K · Dec 27, 2024
• Lixte Biotechnology Holdings Files 8-K on Shareholder Vote Matters — 8-K · Dec 20, 2024
• Lixte Biotechnology Enters Material Definitive Agreement — 8-K · Dec 2, 2024
• LIXTE BIOTECHNOLOGY 10-Q Filing for Q3 2024 — 10-Q · Nov 12, 2024
• Lixte Biotechnology Holdings DEF 14A Filing — DEF 14A · Nov 5, 2024
• Lixte Biotechnology Files S-1/A Amendment — S-1/A · Nov 1, 2024
• Lixte Biotechnology Faces Delisting Concerns — 8-K · Oct 23, 2024
• Lixte Biotechnology Files 8-K — 8-K · Sep 5, 2024
• Lixte Biotechnology Files 8-K — 8-K · Aug 26, 2024
• Lixte Biotechnology Faces Delisting Notice — 8-K · Aug 23, 2024
• Lixte Biotech Raises $1.9M via Stock and Warrant Sale — 8-K · Aug 19, 2024
• Lixte Biotechnology Holdings Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
• Lixte Biotechnology Enters Material Definitive Agreement — 8-K · Jul 12, 2024
• Lixte Biotech Appoints New CMO, Adds Director — 8-K · Jul 11, 2024
• Lixte Biotechnology Enters Material Agreement — 8-K · Jun 14, 2024
• Lixte Biotech Appoints New CMO, Director — 8-K · Jun 5, 2024
• Lixte Biotech Appoints New CMO, Adds Director — 8-K · May 29, 2024
• Lixte Biotechnology Files 8-K — 8-K · May 20, 2024
• LIXTE BIOTECHNOLOGY HOLDINGS, INC. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
• Lixte Biotechnology Holdings Files 8-K — 8-K · Mar 28, 2024
• Lixte Biotechnology Secures $1.5M Funding — 8-K · Mar 22, 2024
• Lixte Biotechnology Holdings, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 19, 2024
• LIXTE Files 8-K on Common Stock & Warrants Activity — 8-K · Feb 27, 2024
• LIXTE Biotech Enters Material Definitive Agreement — 8-K · Feb 26, 2024
• LIXTE Biotech Updates Principal Executive Offices — 8-K · Jan 30, 2024